International Assets Investment Management LLC Makes New Investment in Cronos Group Inc. $CRON

International Assets Investment Management LLC acquired a new stake in Cronos Group Inc. (NASDAQ:CRON) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,265 shares of the company’s stock, valued at approximately $33,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Mraz Amerine & Associates Inc. purchased a new stake in shares of Cronos Group in the second quarter valued at $57,000. Goldman Sachs Group Inc. lifted its position in shares of Cronos Group by 84.6% in the first quarter. Goldman Sachs Group Inc. now owns 1,076,405 shares of the company’s stock valued at $1,948,000 after acquiring an additional 493,161 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of Cronos Group by 291.6% in the first quarter. Jones Financial Companies Lllp now owns 65,099 shares of the company’s stock valued at $118,000 after acquiring an additional 48,476 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Cronos Group in the first quarter valued at $341,000. Finally, Aigen Investment Management LP purchased a new stake in shares of Cronos Group in the first quarter valued at $35,000. 8.71% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CRON. Weiss Ratings restated a “sell (d+)” rating on shares of Cronos Group in a research report on Friday. Wall Street Zen upgraded Cronos Group from a “sell” rating to a “hold” rating in a research note on Saturday, August 30th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Cronos Group Trading Up 1.6%

Cronos Group stock opened at $2.52 on Friday. The firm has a market capitalization of $964.88 million, a P/E ratio of 50.40 and a beta of 1.12. The stock has a fifty day moving average price of $2.57 and a 200 day moving average price of $2.19. Cronos Group Inc. has a 52 week low of $1.60 and a 52 week high of $3.16.

Cronos Group (NASDAQ:CRON) last released its earnings results on Thursday, August 7th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.08). The business had revenue of $33.46 million during the quarter, compared to analyst estimates of $45.73 million. Cronos Group had a net margin of 14.19% and a negative return on equity of 3.78%. As a group, equities analysts predict that Cronos Group Inc. will post -0.03 EPS for the current year.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.